• Bioactive Molecules • Building Blocks • Intermediates www.ChemScene.com Bioactive Compound Library Plus (96-well) Product Details: Catalog Number: CS-L001P Formulation: A collection of 13195 bioactive compounds supplied as pre-dissolved Solutions or Solid Container: 96- or 384-well Plate with Peelable Foil Seal; 96-well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode Storage: -80°C Shipping: Blue ice Packaging: Inert gas Plate layout: CS-L001P-Part A-1 1 2 3 4 5 6 7 8 9 10 11 12 SKF-96365 Fumarate MRT68921 a Empty (hydrochlorid ML162 ML-210 hydratase-IN- (dihydrochlori Vonoprazan Peretinoin Ufenamate SR-3029 CBR-5884 Empty e) 1 de) (1R,2R)-2- 2-PCCA HLCL-61 b Empty PCCA (hydrochlorid Mivebresib AZD0156 BAY-876 BAY1125976 BAY-1436032 Tomivosertib LY3177833 (hydrochlorid Empty (hydrochlorid e) e) Ro 41-1049 c Empty PQR620 (hydrochlorid AT-130 Bay 41-4109 PD 117519 NSC 663284 MK-4101 YYA-021 Faropenem Bromobimane Empty e) (racemate) daloxate Flavopiridol 2- 9- (Z)-9- Dolutegravir d Empty Flavopiridol (Hydrochlorid (Dimethylami NPS-2143 Propenyladen Propenyladen SNS-032 intermediate- Semagacesta Ko 143 Empty e) no)acetaldeh ine ine 1 t AT2 receptor Mitoquinone JNJ- e Empty KNK437 GLX351322 agonist C21 TA-01 TA-02 (mesylate) BW-A 78U AZD-5438 Tubercidin 17203212 Empty N-[(4- Taranabant f Empty Taranabant Aminophenyl) GSK481 Taranabant ((1R,2R)stere R547 Pipequaline Pirozadil PAP-1 4-IBP Empty methyl]adeno (racemate) oisomer) Toll-like g Empty E 2012 SDZ-MKS BAPTA SCH 546738 receptor Delpazolid DSM265 GSK- Varenicline SAR-020106 Empty 492 modulator 2881078 Pyrroloquinoli Varenicline h Empty Pyrroloquinoli ne quinone HUHS015 (Hydrochlorid SMER28 A-196 TPEN CP21R7 HC-067047 Varenicline Empty ne quinone (disodium e) (Tartrate) Plate layout: CS-L001P-Part A-2 1 2 3 4 5 6 7 8 9 10 11 12 Biotin DL-3- a Empty EAI045 Hydrazide Indolylglycine RSL3 GSK6853 AM-2394 CZ415 Calpeptin SANT-1 ME0328 Empty SKF89976A ML133 b Empty A-205804 E 64c (hydrochlorid Aloxistatin (hydrochlorid IQ-1S (free DREADD GSK591 Madrasin SZL P1-41 Empty e) e) acid) agonist 21 Rho-Kinase- Tyrosine c Empty CI-1044 Trifarotene IN-1 Org41841 Naminidil Mifobate Nutlin-3a KW-8232 9-amino-CPT kinase-IN-1 Empty SRI-011381 d Empty MCHR1 PCI-33380 AC260584 WWL70 GSK583 M2I-1 GNE-495 PK14105 (hydrochlorid EPI-001 Empty antagonist 2 e) AQ-13 MELK-8a DMCM e Empty CA-074 BI-7273 BI-9564 dihydrochlorid CL-82198 MS049 Remetinostat Lu AF21934 (hydrochlorid (hydrochlorid Empty methyl ester e e) e) Isavuconazon Diroximel TPO agonist Nigericin f Empty Quiflapon MRK-016 (RS)-MCPG ium (sulfate) fumarate Valrocemide A 922500 1 (sodium salt) FPTQ Empty SHP099 g Empty BH3I-1 NKL 22 Brevianamide SHP099 (hydrochlorid (S)- NVP- F16 SQ22536 PF-04979064 Empty F e) ML753286 BAW2881 K-604 h Empty Nevanimibe dihydrochlorid Pactimibe Pactimibe CFMTI Ro 67-7476 JNJ16259685 GNF-6231 PHCCC FCCP Empty hydrochloride e (sulfate) Plate layout: CS-L001P-Part A-3 1 2 3 4 5 6 7 8 9 10 11 12 Address: 1 Deer Park Dr, Suite Q, Monmouth Junction, NJ 08852, USA Tel: 732-484-9848 Fax: 888-484-5008 Email: [email protected] • Bioactive Molecules • Building Blocks • Intermediates www.ChemScene.com LY2365109 a Empty MLi-2 Linaprazan UKI-1 (hydrochlorid BFH772 Odanacatib CPI-455 KDM5-IN-1 Imazamox CAN508 Empty e) gamma- Empty CCF642 IMR-1 IMR-1A PACMA 31 PD-161570 Cadazolid HA15 secretase WYE-132 Treprostinil Empty b modulator 1 αvβ1 integrin- TM5275 c Empty Paquinimod IN-1 (TFA) (sodium) AEE788 TCS-OX2-29 HO-3867 CGP 25454A ZL006 IC87201 GSK3179106 Empty REV7/REV3L d Empty Plerixafor C29 PTP1B-IN-2 TPI-1 -IN-1 NSC781406 Esaxerenone ZYZ-488 Visomitin CPI-637 Empty Rilmenidine e Empty A-804598 BTTAA TAK-243 Bay 59-3074 TBHQ (hemifumarat Rilmenidine Fisogatinib BP-1-102 SH5-07 Empty e) (phosphate) Tyrphostin f Empty FT011 GSK2256098 AG 528 M2698 CID5721353 GLPG0187 Avadomide ITSA-1 NPS-1034 RAF709 Empty Benzophenon Benzenepent GSK484 g Empty etetracarboxyl acarboxylic (hydrochlorid T-26c NVS-PAK1-1 Aprepitant GKI-1 FMK 9a ML385 LRE1 Empty ic acid Acid e) Nanchangmy Sp-cAMPS h Empty XMU-MP-1 AN2718 cin Dianemycin PD150606 Maropitant (sodium salt) DprE1-IN-2 CD437 IDE1 Empty Plate layout: CS-L001P-Part A-4 1 2 3 4 5 6 7 8 9 10 11 12 D-α- GSK-LSD1 a Empty DTP3 DTP3 (TFA) Golgicide A Golgicide A-2 Golgicide A-1 INH6 Hydroxyglutar FLLL32 BAPTA-AM (dihydrochlori Empty ic acid de) Cyclo(RGDyK Empty GSK621 (S)-Crizotinib MSDC 0160 meso- Tie2 kinase SecinH3 Abscisic acid Tempol Flopropione ) Empty b Erythritol inhibitor 1 (trifluoroaceta Cl-amidine c Empty SGC2085 Necrosulfona (hydrochlorid Acriflavine NH125 AGK2 Ferrostatin-1 Asaraldehyde CORM-3 Ribitol Empty mide e) VU0364770 d Empty (-)-(S)-Equol (±)-Equol Davercin Splitomicin D-Glutamine VU0364770 (hydrochlorid SirReal2 Nicaraven Spiramycin Empty e) Sodium Landiolol e Empty stibogluconat AS1842856 Saponins Urolithin A BGG463 HJC0152 (hydrochlorid BMS453 4-P-PDOT CaCCinh-A01 Empty e hydrochloride e) BMS-986020 Roflumilast N- f Empty T16Ainh-A01 AS1517499 Hispidin BMS-986020 (sodium) BVT948 WNK463 APS-2-79 FGFR4-IN-1 oxide Empty AZD5153 (6- Empty Ticagrelor Axitinib Hydroxy-2- Didesethyl Fosfluconazol Mycro 3 Y-33075 L002 SR59230A LM22A-4 Empty g naphthoic chloroquine e Y-33075 h Empty JTE-013 CGS 15943 GSK2837808 MS-444 U93631 GNF-PF-3777 ML390 Propyl (dihydrochlori NOD-IN-1 Empty A pyrazole triol de) Plate layout: CS-L001P-Part A-5 1 2 3 4 5 6 7 8 9 10 11 12 Lin28-let-7a a Empty antagonist 1 SYP-5 TPOP146 Pipamperone NSC632839 Y-27632 D-AP5 Eganelisib HT-2157 BRD-6929 Empty Histone b Empty GSK2193874 BM212 GNE-272 AM-2099 BMT-145027 GSK9311 Cambinol 4E2RCat Acetyltransfer C 87 Empty ase Inhibitor II (1α,1'S,4β)- GNE-140 c Empty ML348 ML349 RA190 TPCA-1 Lanabecestat Lanabecestat S63845 (racemate) (R)-GNE-140 (S)-GNE-140 Empty Norverapamil d Empty AS8351 STF-62247 PSB-12379 CXD101 (hydrochlorid STAT3-IN-1 Ritlecitinib (2R,5S)- KR-33493 FUBP1-IN-1 Empty e) Ritlecitinib L-AP4 (-)-Bicuculline e Empty Toxoflavin HTHQ YL0919 PCC0208009 Setogepram Rimacalib (monohydrate (methobromid gamma-DGG 2-PMPA Empty (sodium salt) ) e) Pirmenol f Empty CHS-828 Ciliobrevin A NSC23005 URB602 SR12813 (hydrochlorid Teglarinad Hypotaurine Kynurenic Quinolinic Empty (sodium) e) (chloride) acid acid Isoguvacine 7- 7- (RS)-AMPA g Empty D-Serine Guvacine GS-6201 (hydrochlorid Chlorokynure Chlorokynure (monohydrate Rbin-1 Futibatinib 3-AP Empty hydrochloride e) nic acid nic acid ) OABK Piperoxan h Empty (hydrochlorid BGP-15 NCB-0846 YM-58483 UNC3866 Antibiotic-5d GS-444217 JQEZ5 (hydrochlorid IWP-O1 Empty e) e) Plate layout: CS-L001P-Part A-6 Address: 1 Deer Park Dr, Suite Q, Monmouth Junction, NJ 08852, USA Tel: 732-484-9848 Fax: 888-484-5008 Email: [email protected] • Bioactive Molecules • Building Blocks • Intermediates www.ChemScene.com 1 2 3 4 5 6 7 8 9 10 11 12 TAK-659 a Empty PCO371 BRCA1-IN-2 (hydrochlorid Navitoclax ABX464 WT-161 KRIBB11 PF-1355 Bisantrene GGTI298 Empty e) ONO- (R)- b Empty GCN2-IN-1 Zibotentan TUG-891 7300243 Acelarin BAY1082439 Simurosertib Simurosertib CD80-IN-3 MX69 Empty Norbinaltorphi (±)- W-7 c Empty SAR-20347 OGT 2115 ML364 CDD3505 CDD3506 mine Acetylcarnitin (hydrochlorid ML-9 MY-5445 Empty dihydrochlorid e (chloride) e) Cinanserin ATM-3507 d Empty DPCPX CCCP (hydrochlorid Conduritol B CEP-40783 VH-298 (trihydrochlori Olcegepant Beaucage CYM-5520 Empty e) epoxide de) reagent 2,4-Diamino- Dilazep Diphenylenei Adenosine 5′- e Empty 6- Flurofamide (dihydrochlori (E)-AG 99 odonium 4F 4PP Spiramide diphosphorib TB5 HA-100 Empty hydroxypyrimi de) chloride (oxalate) ose (sodium) L-NIO f Empty (dihydrochlori FG 7142 10074-G5 NPPB MK-8617 Nrf2-IN-1 CCT251236 GSK 4027 GSK4028 ZINC1346675 Empty de) 1 ZK756326 AR-M g Empty RIPA-56 LOM612 Choline Sarcosine (dihydrochlori 1000390 Q203 AG-494 D-erythro- Src Inhibitor 1 Empty (bitartrate) de) (hydrochlorid Sphingosine Kinetin L-690330 h Empty NQ301 riboside Brensocatib TOFA Y-26763 Monastrol Salermide (hydrate) LY294002 NSC 228155 Empty Plate layout: CS-L001P-Part A-7 1 2 3 4 5 6 7 8 9 10 11 12 Acetylcholine a Empty SKL2001 (iodide) CeMMEC13 RHPS4 AS-605240 KYA1797K Importazole Ocaperidone MK-8998 PD-1-IN-17 Empty (2- SB-224289 b Empty IC-87114 Hydroxypropy (hydrochlorid AR7 TG100-115 PF-06840003 GLP-1R EED226 666-15 TP-3654 Empty l)-β- e) Antagonist 1 PI-103 c Empty Bicyclomycin PNU-74654 Dansyl TGX-221 PGMI-004A SF2523 PI-103 (Hydrochlorid 3-Bromo-7- 2- Empty benzoate glutathione e) nitroindazole Iodomelatonin Naltrindole Tin- d Empty (hydrochlorid Tesmilifene Filibuvir C2 Ceramide T807 JNJ- Vorapaxar Ecteinascidin GSK682753A protoporphyri Empty e) (fumarate) 39758979 770 n IX SB-203186 e Empty GJ103 Asenapine UK-371804 Org-26576 BI 689648 Silodosin (hydrochlorid Tiotidine DHBP Agmatine Empty (sodium salt) e) (dibromide) (sulfate) Oxotremorine AM-92016 f Empty (sesquifumar XMD16-5 ZINC0088152 RPI-1 L-732138 (hydrochlorid Luzindole ODQ YKL-5-124 YKL-5-124 Empty ate) 4 e) (TFA) Milademetan g Empty Barasertib- CCR2 S1p receptor (tosylate CHMFL-BMX- Barasertib STK16-IN-1 WAY-200070 GDC-0326 BAR502 Empty HQPA antagonist 3 agonist 1 hydrate) 078 EMT inhibitor- (R)-VU h Empty BAR501 1 Vadadustat Thiomyristoyl ST034307 ZM-447439 VU 6008667 6008667 HCH6-1 DMU2105 Empty Plate layout: CS-L001P-Part A-8 1 2 3 4 5 6 7 8 9 10 11 12 Dihydrexidine Veliparib a Empty DMU2139 Veliparib Iberdomide FK614 TPPU Pan-RAS-IN- PD-166866 Paprotrain (hydrochlorid (dihydrochlori Empty 1 e) de) Cirazoline AHN 1-055 b Empty (hydrochlorid Cilostamide (hydrochlorid Phenylbiguan RS 17053 ZD7288 L-741626 R-IMPP 8-M-PDOT Hesperin Empty e) e)